Frank Shann

ORCID: 0000-0002-9899-1804
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune responses and vaccinations
  • Pneumonia and Respiratory Infections
  • Sepsis Diagnosis and Treatment
  • Neonatal Respiratory Health Research
  • Vaccine Coverage and Hesitancy
  • Respiratory viral infections research
  • Respiratory Support and Mechanisms
  • Mechanical Circulatory Support Devices
  • Emergency and Acute Care Studies
  • Bacterial Infections and Vaccines
  • Cardiac, Anesthesia and Surgical Outcomes
  • Child Nutrition and Water Access
  • Immunodeficiency and Autoimmune Disorders
  • Airway Management and Intubation Techniques
  • Antibiotics Pharmacokinetics and Efficacy
  • Family and Patient Care in Intensive Care Units
  • Cardiac Arrest and Resuscitation
  • Child and Adolescent Health
  • Hemodynamic Monitoring and Therapy
  • Infant Development and Preterm Care
  • Congenital Heart Disease Studies
  • Thermal Regulation in Medicine
  • Tracheal and airway disorders
  • Congenital Diaphragmatic Hernia Studies
  • Tuberculosis Research and Epidemiology

The University of Melbourne
2015-2024

Florey Institute of Neuroscience and Mental Health
2024

Royal Children's Hospital
2013-2022

Office of Infectious Diseases
2021

Murdoch Children's Research Institute
2011-2016

Queensland Children’s Hospital
2016

Children's Hospital at Westmead
2016

Sydney Children's Hospital
2016

Women's and Children's Hospital
2016

Intensive Care Society
2009-2013

To provide an updated version of the Paediatric Index Mortality 2 for assessing risk mortality among children admitted to ICU.International, multicenter, prospective cohort study.Sixty ICUs that accept pediatric admissions in Australia, New Zealand, Ireland, and United Kingdom.All 2010 2011 younger than 18 years old at time admission either died ICU or were discharged. Patients who transferred another not included. Fifty-three thousand one hundred twelve patient included analysis.None.A...

10.1097/pcc.0b013e31829760cf article EN Pediatric Critical Care Medicine 2013-07-17

To describe the characteristics of children admitted to intensive care in 1982, 1995, and 2005-2006, their long-term outcome.Pediatric unit a university-affiliated children's hospital.Information for 2005-2006 admissions was obtained from pediatric database, outcome ascertained through telephone interviews. Results were compared previous cohorts 1982 1995.A total 4010 on 5250 occasions. Readmissions increased 11% 31% 2005 2006 (p < .001). In fewer after accidents .001), or with croup...

10.1097/pcc.0b013e3181ce7427 article EN Pediatric Critical Care Medicine 2010-03-26

10.1097/00006454-198603000-00017 article EN The Pediatric Infectious Disease Journal 1986-03-01

Objective: To assess the effect of plasmafiltration (PF) on biochemical markers inflammation, cytokines, organ dysfunction, and 14-day mortality in human sepsis. Design: Multicenter, prospective, randomized, controlled clinical trial. Setting: Seven university-affiliated intensive care units. Patients: Thirty patients (22 adults, eight children) with new (<24 hrs) evidence infection sepsis syndrome were enrolled. Fourteen 30 (nine five randomized to PF. Interventions: All received...

10.1097/00003246-199910000-00003 article EN Critical Care Medicine 1999-10-01

Bacille Calmette-Guérin (BCG), the live attenuated tuberculosis vaccine, is manufactured under different conditions across globe generating formulations that may differ in clinical efficacy. Innate immune recognition of BCG contributes to immunogenicity suggesting differences viability contribute divergent activity licensed formulations.We compared BCG-Denmark (DEN), -Japan (JPN), -India (IND), -Bulgaria (BUL) and -USA vitro with respect a) as measured by colony-forming units (CFU),...

10.1016/j.vaccine.2019.11.060 article EN cc-by-nc-nd Vaccine 2020-01-28

Objective: To compare the performance of Pediatric Index Mortality (PIM), PIM2, Risk (PRISM), and PRISM III in Australia New Zealand. Design: A two-phase prospective observational study. Phase 1 assessed PIM, PRISM, between 1997 1999. 2 PIM2 2000 2001. Setting: Ten intensive care units Patients: Included study were 26,966 patients aged <16 yrs; 1,147 died unit. Interventions: None. Measurements Main Results: Discrimination death survival was by calculating area under receiver operating...

10.1097/01.pcc.0000138557.31831.65 article EN Pediatric Critical Care Medicine 2004-08-26

Infection with antibiotic-resistant (AR) Gram-negative (GN) bacteria is associated increased morbidity and mortality. The aim of this study was to determine risk factors outcomes GN bacteremia acquired resistance antibiotics used in the empiric treatment febrile neutropenia pediatric oncology patients at our institution.All episodes Royal Children's Hospital Melbourne, from 2003 2010 were retrospectively reviewed. Information regarding age, diagnosis, phase treatment, inpatient status,...

10.1097/inf.0b013e31828aebc8 article EN The Pediatric Infectious Disease Journal 2013-02-22

The current framework for testing and regulating vaccines was established before the realization that vaccines, in addition to their effect against vaccine-specific disease, may also have "non-specific effects" affecting risk of unrelated diseases. Accumulating evidence from epidemiological studies shows some situations can affect all-cause mortality morbidity ways are not explained by prevention vaccine-targeted disease. Live attenuated sometimes been associated with decreases greater than...

10.1007/s40264-023-01295-3 article EN cc-by-nc Drug Safety 2023-04-19
Coming Soon ...